Pursuing common interests

Given the rapidly growing demand for validated genetic content among organizations that market high-value diagnostics, there is significant room for value creation in the marketing and commercialization of these tests. We are currently executing a plan to commercialize these findings both directly and through partnerships with existing diagnostics companies, pharmaceutical companies, public and private payers, and CLIA-certified laboratories.

For information about partnering and licensing opportunities, please contact businessdevelopment@perlegen.com